• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝普钠(HNO)靶向肌球蛋白轻链磷酸酶靶蛋白(phospholamban)半胱氨酸 41 和 46 以增强心脏功能。

Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function.

机构信息

Department of Chemistry, Johns Hopkins University, Baltimore, MD.

Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD.

出版信息

J Gen Physiol. 2019 Jun 3;151(6):758-770. doi: 10.1085/jgp.201812208. Epub 2019 Mar 6.

DOI:10.1085/jgp.201812208
PMID:30842219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6571998/
Abstract

Nitroxyl (HNO) positively modulates myocardial function by accelerating Ca reuptake into the sarcoplasmic reticulum (SR). HNO-induced enhancement of myocardial Ca cycling and function is due to the modification of cysteines in the transmembrane domain of phospholamban (PLN), which results in activation of SR Ca-ATPase (SERCA2a) by functionally uncoupling PLN from SERCA2a. However, which cysteines are modified by HNO, and whether HNO induces reversible disulfides or single cysteine sulfinamides (RS(O)NH) that are less easily reversed by reductants, remain to be determined. Using an N-edited NMR method for sulfinamide detection, we first demonstrate that Cys46 and Cys41 are the main targets of HNO reactivity with PLN. Supporting this conclusion, mutation of PLN cysteines 46 and 41 to alanine reduces the HNO-induced enhancement of SERCA2a activity. Treatment of WT-PLN with HNO leads to sulfinamide formation when the HNO donor is in excess, whereas disulfide formation is expected to dominate when the HNO/thiol stoichiometry approaches a 1:1 ratio that is more similar to that anticipated in vivo under normal, physiological conditions. Thus, N-edited NMR spectroscopy detects redox changes on thiols that are unique to HNO, greatly advancing the ability to detect HNO footprints in biological systems, while further differentiating HNO-induced post-translational modifications from those imparted by other reactive nitrogen or oxygen species. The present study confirms the potential of HNO as a signaling molecule in the cardiovascular system.

摘要

硝酰(HNO)通过加速肌浆网(SR)内 Ca 的重摄取,积极调节心肌功能。HNO 诱导的心肌 Ca 循环和功能增强归因于磷蛋白(PLN)跨膜域中半胱氨酸的修饰,这导致 PLN 与 SERCA2a 的功能解偶联,从而激活 SR Ca-ATP 酶(SERCA2a)。然而,HNO 修饰了哪些半胱氨酸,以及 HNO 是否诱导可逆的二硫键或单半胱氨酸亚磺酰胺(RS(O)NH),还原剂较难还原这些二硫键或单半胱氨酸亚磺酰胺,这些仍有待确定。我们使用 N 编辑 NMR 方法检测亚磺酰胺,首次证明 Cys46 和 Cys41 是 HNO 与 PLN 反应的主要靶标。支持这一结论,PLN 半胱氨酸 46 和 41 突变为丙氨酸可降低 HNO 诱导的 SERCA2a 活性增强。当 HNO 供体过量时,用 HNO 处理 WT-PLN 会导致亚磺酰胺形成,而当 HNO/硫醇计量比接近更接近正常生理条件下体内预期的 1:1 比例时,预计会形成二硫键。因此,N 编辑 NMR 光谱检测到的仅与 HNO 相关的硫醇的氧化还原变化,极大地提高了在生物系统中检测 HNO 足迹的能力,同时进一步区分了 HNO 诱导的翻译后修饰与其他活性氮或氧物种所引起的修饰。本研究证实了 HNO 作为心血管系统信号分子的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/7832676c80af/JGP_201812208_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/1597184afcce/JGP_201812208_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/f1417fa41bab/JGP_201812208_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/98908a2c4022/JGP_201812208_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/3fa0ccb6559c/JGP_201812208_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/d25120f55b5f/JGP_201812208_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/cabb47fb7aeb/JGP_201812208_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/d3050535bbd4/JGP_201812208_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/7832676c80af/JGP_201812208_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/1597184afcce/JGP_201812208_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/f1417fa41bab/JGP_201812208_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/98908a2c4022/JGP_201812208_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/3fa0ccb6559c/JGP_201812208_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/d25120f55b5f/JGP_201812208_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/cabb47fb7aeb/JGP_201812208_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/d3050535bbd4/JGP_201812208_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/6571998/7832676c80af/JGP_201812208_Fig8.jpg

相似文献

1
Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function.硝普钠(HNO)靶向肌球蛋白轻链磷酸酶靶蛋白(phospholamban)半胱氨酸 41 和 46 以增强心脏功能。
J Gen Physiol. 2019 Jun 3;151(6):758-770. doi: 10.1085/jgp.201812208. Epub 2019 Mar 6.
2
HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.HNO 通过促进氧化还原依赖的肌球蛋白轻链磷酸酶锚定蛋白寡聚化来增强 SERCA2a 活性和心肌细胞功能。
Antioxid Redox Signal. 2013 Oct 10;19(11):1185-97. doi: 10.1089/ars.2012.5057.
3
Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl.磷肌酸的硫醇在硝酰激活心肌肌浆网钙泵过程中起核心作用。
Biochemistry. 2008 Dec 16;47(50):13150-2. doi: 10.1021/bi801925p.
4
Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors.硝酰通过氧化兰尼碱受体触发骨骼肌和心肌肌浆网释放Ca2+。
Cell Calcium. 2005 Jan;37(1):87-96. doi: 10.1016/j.ceca.2004.07.001.
5
Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674.硝酰通过半胱氨酸674的谷胱甘肽化作用激活心肌细胞中的肌浆网钙ATP酶。
Circ Res. 2009 Mar 27;104(6):720-3. doi: 10.1161/CIRCRESAHA.108.188441. Epub 2009 Mar 5.
6
NMR detection and study of hydrolysis of HNO-derived sulfinamides.NMR 检测及 HNO 衍生亚磺酰胺水解研究。
Biochemistry. 2013 Oct 22;52(42):7387-96. doi: 10.1021/bi401110f. Epub 2013 Oct 7.
7
Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function.硝酰基介导的心肌丝半胱氨酸之间的二硫键形成增强了收缩功能。
Circ Res. 2012 Sep 28;111(8):1002-11. doi: 10.1161/CIRCRESAHA.112.270827. Epub 2012 Jul 31.
8
Nitroxyl increases force development in rat cardiac muscle.硝酰增加大鼠心肌的力发展。
J Physiol. 2007 May 1;580(Pt.3):951-60. doi: 10.1113/jphysiol.2007.129254. Epub 2007 Mar 1.
9
Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.可溶性鸟苷酸环化酶是小鼠体内全身血管舒张所必需的,但不是硝酰诱导的正性肌力作用所必需的。
Hypertension. 2015 Feb;65(2):385-92. doi: 10.1161/HYPERTENSIONAHA.114.04285. Epub 2014 Dec 1.
10
Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method.使用新型质谱检测方法鉴定人血小板蛋白中硝酰基诱导的修饰。
Mol Cell Proteomics. 2009 May;8(5):887-903. doi: 10.1074/mcp.M800230-MCP200. Epub 2008 Dec 31.

引用本文的文献

1
Genetic landscape of phospholamban cardiomyopathies.受磷蛋白心肌病的遗传图谱
Front Cell Dev Biol. 2025 Jun 10;13:1626242. doi: 10.3389/fcell.2025.1626242. eCollection 2025.
2
β3AR-Dependent Brain-Derived Neurotrophic Factor (BDNF) Generation Limits Chronic Postischemic Heart Failure.β3AR 依赖性脑源性神经营养因子(BDNF)生成限制慢性缺血性心力衰竭。
Circ Res. 2023 Mar 31;132(7):867-881. doi: 10.1161/CIRCRESAHA.122.321583. Epub 2023 Mar 8.
3
Antiglycation and Antioxidant Effect of Nitroxyl towards Hemoglobin.硝酰基对血红蛋白的抗糖化和抗氧化作用

本文引用的文献

1
A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.近期的亚硝酰化学、药理学和治疗潜力历史。
Br J Pharmacol. 2019 Jan;176(2):135-146. doi: 10.1111/bph.14384. Epub 2018 Jul 1.
2
Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.亚硝酰自由基(HNO)供体在急性失代偿性心力衰竭治疗中的潜在作用。
Drugs. 2016 Sep;76(14):1337-48. doi: 10.1007/s40265-016-0631-y.
3
Metal-based optical probes for live cell imaging of nitroxyl (HNO).基于金属的光学探针用于活细胞中硝酰自由基(HNO)的成像。
Antioxidants (Basel). 2022 Oct 11;11(10):2007. doi: 10.3390/antiox11102007.
4
Tandem Mass Tagging Based Identification of Proteome Signatures for Reductive Stress Cardiomyopathy.基于串联质量标签的还原应激性心肌病蛋白质组特征鉴定
Front Cardiovasc Med. 2022 Jun 13;9:848045. doi: 10.3389/fcvm.2022.848045. eCollection 2022.
5
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance.硝普盐(Angeli's salt)作为一种新型内源性一氧化氮供体,具有抗氧化、清除自由基、抑制炎症反应、保护内皮细胞等多种作用。 **解析**:在面对一氧化氮抵抗的情况下,硝普盐(Angeli's salt)作为一种新型内源性一氧化氮供体,仍然能够保护心脏和血管,具有抗氧化、清除自由基、抑制炎症反应、保护内皮细胞等多种作用。
Br J Pharmacol. 2022 Aug;179(16):4117-4135. doi: 10.1111/bph.15849. Epub 2022 Apr 26.
6
Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.线粒体肌酸激酶可减轻心力衰竭中的病理性重构。
Circ Res. 2022 Mar 4;130(5):741-759. doi: 10.1161/CIRCRESAHA.121.319648. Epub 2022 Feb 3.
7
Kinetics of Azanone (HNO) Reactions with Thiols: Effect of pH.氮氧化物(HNO)与硫醇的反应动力学:pH 值的影响。
Cell Biochem Biophys. 2021 Dec;79(4):845-856. doi: 10.1007/s12013-021-00986-x. Epub 2021 May 5.
8
Regulation of Cardiac PKA Signaling by cAMP and Oxidants.环磷酸腺苷(cAMP)和氧化剂对心脏蛋白激酶A(PKA)信号通路的调节
Antioxidants (Basel). 2021 Apr 24;10(5):663. doi: 10.3390/antiox10050663.
9
Phosphorylated cofilin-2 is more prone to oxidative modifications on Cys39 and favors amyloid fibril formation.磷酸化的肌动蛋白结合蛋白 2 更容易在半胱氨酸 39 位发生氧化修饰,并有利于淀粉样纤维的形成。
Redox Biol. 2020 Oct;37:101691. doi: 10.1016/j.redox.2020.101691. Epub 2020 Aug 25.
10
Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.氧化还原对兄弟,一氧化氮(NO•)和亚硝酰(HNO)在活性氧物种失调情况下的心血管治疗潜力。
Handb Exp Pharmacol. 2021;264:311-337. doi: 10.1007/164_2020_389.
Acc Chem Res. 2015 Nov 17;48(11):2927-34. doi: 10.1021/acs.accounts.5b00388. Epub 2015 Nov 9.
4
S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.心脏肾上腺素能信号传导与肥大过程中钙处理蛋白的S-亚硝基化作用
Circ Res. 2015 Oct 9;117(9):793-803. doi: 10.1161/CIRCRESAHA.115.307157. Epub 2015 Aug 10.
5
Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.可溶性鸟苷酸环化酶是小鼠体内全身血管舒张所必需的,但不是硝酰诱导的正性肌力作用所必需的。
Hypertension. 2015 Feb;65(2):385-92. doi: 10.1161/HYPERTENSIONAHA.114.04285. Epub 2014 Dec 1.
6
Reactivity of C-terminal cysteines with HNO.C 末端半胱氨酸与 HNO 的反应性。
Biochemistry. 2014 Jun 10;53(22):3689-98. doi: 10.1021/bi500360x. Epub 2014 May 28.
7
Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation.时间分辨荧光共振能量转移揭示 SERCA-PLB 调节的结构机制。
Biochem Biophys Res Commun. 2014 Jun 27;449(2):196-201. doi: 10.1016/j.bbrc.2014.04.166. Epub 2014 May 9.
8
Structural dynamics and topology of phosphorylated phospholamban homopentamer reveal its role in the regulation of calcium transport.磷酸化肌浆球蛋白结合蛋白同五聚体的结构动力学和拓扑结构揭示了其在钙转运调节中的作用。
Structure. 2013 Dec 3;21(12):2119-30. doi: 10.1016/j.str.2013.09.008. Epub 2013 Oct 24.
9
Nitroxyl (HNO): A novel approach for the acute treatment of heart failure.硝普氢(HNO):心力衰竭急性治疗的新方法。
Circ Heart Fail. 2013 Nov;6(6):1250-8. doi: 10.1161/CIRCHEARTFAILURE.113.000632. Epub 2013 Oct 9.
10
Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban.通过肌球蛋白结合蛋白 C 的磷酸化介导的构象变化对 SERCA 的变构调节。
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17338-43. doi: 10.1073/pnas.1303006110. Epub 2013 Oct 7.